SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-003820
Filing Date
2020-04-28
Accepted
2020-04-28 16:33:28
Documents
1
Period of Report
2020-04-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-48642.html 4  
1 PRIMARY DOCUMENT marketforms-48642.xml 4 3292
  Complete submission text file 0001214659-20-003820.txt   4818
Mailing Address 689 5TH AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 20825589

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)